RECENT NEWS

On Thursday 5 June hospital laboratories across the UK marked Biomedical Science Day 2025 - a national celebration of the scientists and laboratory staff whose work underpins patient care.

Cytek Biosciences has announced the launch of the Cytek Aurora Evo system, a new full-spectrum flow cytometer that improves on its flagship Cytek Aurora system.

Fujifilm Corporation's Life Sciences Group companies, a portfolio of businesses which spans all stages of therapeutic development from discovery through to commercialisation, have announced new names and identities as part of a strategic positioning effort.

Researchers at US health group Mass General Brigham have developed a novel diagnostic tool which uses bioluminescence to more accurately identify viruses including SARS-CoV-2, HIV, HBV, and HCV in patient samples.

Genomics England researchers have played a key role in the development of a new artificial intelligence tool, known as SAVANA, that uses long-read sequencing data to find specific changes within a person’s DNA linked to cancer.

Danaher has announced the launch of a partnership with AstraZeneca to develop and commercialise novel diagnostic tools and tests intended to help clinicians better determine which patients would most benefit from precision medicine treatments.

Thousands of NHS patients with lung and breast cancer are to benefit from liquid biopsies, speeding up access to targeted therapy.

Advanced Instruments has announced a definitive agreement to acquire fellow biotechnology company Nova Biomedical.

Mid and South Essex NHS Foundation Trust has signed a 15-year contract with private laboratory services provider SYNLAB, for the delivery of a unified pathology service.

The British people, the NHS and the economy will be better protected against future global health threats thanks to a new World Health Organization Pandemic Agreement adopted by the UK.

UKHSA data shows the influenza vaccine prevented 96,000 to 120,200 hospitalisations in England during last winter.

Anatomic and forensic pathology equipment firm Mopec Group has announced a strategic partnership with Lumea, an innovator in digital pathology and AI-powered workflows.

Neurogen Biomarking and Aranscia, a provider of clinical workflow and diagnostic technology, have announced a partnership in which Aranscia's technical and laboratory resources will help to deliver clinical insights and HIPAA-compliant connectivity for the Neurogen Biomarking ecosystem.

Entries are now open for the Lab Awards, which provides a platform to formally recognise the achievements of the laboratory community across the UK and Ireland.

Roche has announced a strategic collaboration with Broad Clinical Labs to develop and pilot groundbreaking applications using Roche’s recently unveiled next-generation sequencing (NGS) Sequencing By Expansion (SBX) technology.

Barts Health NHS Trust has become the first healthcare provider in the NHS to implement Anonymise and Export from medical imaging IT company Sectra, with large volumes of anonymised diagnostic images available to aid ground-breaking research and medical innovations.

New research from University of Illinois Urbana-Champaign food scientists suggests certain nanoplastics may make foodborne pathogens more virulent.

A review funded as part of Genomics England’s Diverse Data initiative and led by UCL researchers has outlined how the analytical methods used to process and interpret genomic data play a critical role in promoting health equity.

A new study published by health and care charity The King’s Fund uncovers the tough decisions NHS leaders are making to balance their books and protect patient care.

Fujirebio has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse G plasma ratio in vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline.